Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin-II versus noradrenaline for hypotension during liver transplantation
ACTRN12625000506493Phase 2Recruiting
- Sponsor
- Austin Health
- Start
- Mar 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Angiotensin II and norepinephrine in hypotension (2 arms), sponsored by Austin Health. Primary endpoints: Consent rate, Proportional duration of study drug as a percentage of intra-operative time and 1 more. Started Mar 2026; status: recruiting.
02
Drugs
Angiotensin IInorepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on ACTRN12625000506493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000506493.